215 related articles for article (PubMed ID: 11677199)
41. Increased incidence of critical illness among patients with inflammatory bowel disease: a population-based study.
Marrie RA; Garland A; Peschken CA; Hitchon CA; Chen H; Fransoo R; Bernstein CN
Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2063-70.e1-4. PubMed ID: 24726908
[TBL] [Abstract][Full Text] [Related]
42. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years.
Manninen P; Karvonen AL; Huhtala H; Aitola P; Hyöty M; Nieminen I; Hemminki H; Collin P
J Crohns Colitis; 2013 Dec; 7(11):e551-7. PubMed ID: 23619008
[TBL] [Abstract][Full Text] [Related]
43. Histopathological characterization of cholecystectomy specimens in patients with inflammatory bowel disease.
Lin J; Shen B; Lee HJ; Goldblum JR
J Crohns Colitis; 2012 Oct; 6(9):895-9. PubMed ID: 22397872
[TBL] [Abstract][Full Text] [Related]
44. [Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif].
Pagenault M; Tron I; Alexandre JL; Cruchant E; Dabadie A; Chaperon J; Robaszkiewicz M; Bretagne JF
Gastroenterol Clin Biol; 1997; 21(6-7):483-90. PubMed ID: 9295976
[TBL] [Abstract][Full Text] [Related]
45. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
Bjarnason I; Hayee B; Pavlidis P; Kvasnovsky C; Scalori A; Sisson G; Charlesworth A; Shaikh H; Bjornsson E; Heneghan MA
EBioMedicine; 2015 Oct; 2(10):1523-7. PubMed ID: 26629548
[TBL] [Abstract][Full Text] [Related]
46. Loss of response to biologics versus increased risk of lymphoma in children with inflammatory bowel disease: the clinician's conundrum.
Bern EM; Bousvaros A
Expert Rev Clin Immunol; 2013 Feb; 9(2):117-27. PubMed ID: 23390943
[TBL] [Abstract][Full Text] [Related]
47. Increased Risk of Oral Cancer in Patients With Inflammatory Bowel Diseases.
Katsanos KH; Roda G; McBride RB; Cohen B; Colombel JF
Clin Gastroenterol Hepatol; 2016 Mar; 14(3):413-20. PubMed ID: 26499929
[TBL] [Abstract][Full Text] [Related]
48. Prevalence, risk factors and response to treatment of extra-intestinal manifestations in patients with inflammatory bowel disease.
Hernández-Tejero M; Granja Navacerrada A; Bernal Checa P; Piqué Becerra R; Algaba García A; Guerra Marina I; García-Alonso FJ; Syed M; Bermejo F
Rev Esp Enferm Dig; 2017 Sep; 109(9):627-633. PubMed ID: 28747057
[TBL] [Abstract][Full Text] [Related]
49. Survival and cause-specific mortality in inflammatory bowel disease: a population-based cohort study.
Persson PG; Bernell O; Leijonmarck CE; Farahmand BY; Hellers G; Ahlbom A
Gastroenterology; 1996 May; 110(5):1339-45. PubMed ID: 8613037
[TBL] [Abstract][Full Text] [Related]
50. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
[TBL] [Abstract][Full Text] [Related]
51. A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease.
Lutgens M; Vermeire S; Van Oijen M; Vleggaar F; Siersema P; van Assche G; Rutgeerts P; Oldenburg B;
Clin Gastroenterol Hepatol; 2015 Jan; 13(1):148-54.e1. PubMed ID: 25041864
[TBL] [Abstract][Full Text] [Related]
52. Diagnostic problems and advances in inflammatory bowel disease.
Odze R
Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200
[TBL] [Abstract][Full Text] [Related]
53. Cancer and inflammatory bowel disease in the elderly.
Taleban S; Elquza E; Gower-Rousseau C; Peyrin-Biroulet L
Dig Liver Dis; 2016 Oct; 48(10):1105-11. PubMed ID: 27289334
[TBL] [Abstract][Full Text] [Related]
54. [Lymphoproliferative disorders in an inflammatory bowel disease unit].
Van Domselaar M; López San Román A; Bastos Oreiro M; Garrido Gómez E
Gastroenterol Hepatol; 2010 Jan; 33(1):12-6. PubMed ID: 19889478
[TBL] [Abstract][Full Text] [Related]
55. Dual therapy with infliximab and immunomodulator reduces one-year rates of hospitalization and surgery among veterans with inflammatory bowel disease.
Abraham NS; Richardson P; Castillo D; Kane SV
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1281-7. PubMed ID: 23792295
[TBL] [Abstract][Full Text] [Related]
56. Lymphoma risk in children and young adults with inflammatory bowel disease: analysis of a large single-center cohort.
Ashworth LA; Billett A; Mitchell P; Nuti F; Siegel C; Bousvaros A
Inflamm Bowel Dis; 2012 May; 18(5):838-43. PubMed ID: 21887728
[TBL] [Abstract][Full Text] [Related]
57. Is there a risk for lymphoma or extracolonic cancer in patients with inflammatory bowel disease?
Toader E; Ciortescu I
Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):368-74. PubMed ID: 24340518
[TBL] [Abstract][Full Text] [Related]
58. Risk of Stroke in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Xiao Z; Pei Z; Yuan M; Li X; Chen S; Xu L
J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2774-80. PubMed ID: 26360973
[TBL] [Abstract][Full Text] [Related]
59. The cause of death in inflammatory bowel disease: a comparison of death certificates and hospital charts in Rochester, New York.
Nordenholtz KE; Stowe SP; Stormont JM; Stowe MM; Chessin LN; Shah AN; Chey WY
Am J Gastroenterol; 1995 Jun; 90(6):927-32. PubMed ID: 7771423
[TBL] [Abstract][Full Text] [Related]
60. Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort.
van den Heuvel TR; Wintjens DS; Jeuring SF; Wassink MH; Romberg-Camps MJ; Oostenbrug LE; Sanduleanu S; Hameeteman WH; Zeegers MP; Masclee AA; Jonkers DM; Pierik MJ
Int J Cancer; 2016 Sep; 139(6):1270-80. PubMed ID: 27170593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
